Medical device procedures are increasingly going the minimally invasive route. You have transcatheter aortic valve replacement emerging as a superior alternative to open-heart surgery for people with ...
CHICAGO, IL–Use of a large-bore vascular closure device tested in patients undergoing transcatheter aortic valve replacement and endovascular aortic repair procedures appears to be safe and effective ...
The use of vascular closure devices was associated with significant reductions in vascular complications and need for transfusion in patients undergoing transfemoral PCI, according to findings in a ...
Please provide your email address to receive an email when new articles are posted on . Essential Medical, Inc. announced that it has received Investigational Device Exemption approval from the FDA to ...
In patients undergoing transfemoral coronary angiography and percutaneous coronary intervention (PCI), use of a vascular closure device results in reduced rates of complications compared with manual ...
Irish devicemaker Vasorum got FDA approval for its Celt ADC vascular closure device that is aimed at arterial puncture closure. The device is indicated for both diagnostic and anticoagulated ...
WASHINGTON, DC — A large study testing two different vascular-closure devices suggests that they are as good as manual compression for reducing vascular-site complications among patients undergoing ...
The Department of Medicine is proud to celebrate the Electrophysiology Team for being the first in the world to perform a procedure using a new vascular closure system. The new device helps stop ...
Surgery Linked to Cardiac Death in Cancer Patients Vascular closure devices (VCDs) are associated with a significant reduction in vascular complications and post-procedure transfusions. (HealthDay ...
Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug-based vascular closure ...
Chicago, IL - A new vascular closure device with a bioabsorbable plug has shown impressive results in a pivotal multicenter trial, ECLIPSE. The device, named ExoSeal (Cordis), also has a unique ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The major drivers for this market include the large number of approvals for vascular closure devices, the high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results